Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-15

Clinical Trial Update: Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study [Phase 2]

View source ↗

Summary

Phase II single-arm prospective trial evaluating pemetrexed as salvage therapy in metastatic colorectal cancer after failure of standard chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed (pemetrexed)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN